Iguratimod efficacy in palindromic rheumatism treatment
Abstract Background As a new immunomodulator for rheumatoid arthritis, iguratimod (IGU) also has therapeutic potential in other immune diseases. In this study, we determined the effects of IGU on disease control in patients with palindromic rheumatism (PR). Methods Patients with PR were divided into...
Saved in:
| Main Authors: | Fangfang Yuan, Junhong He, Jing Luo, Xin Zhang, Jixia Lin, Yahui Chen, Haiyan Huang, Qiong Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-06-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.932 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of iguratimod in the treatment of patients with palindromic rheumatism ineffective to methotrexate or hydroxychloroquine
by: Mengjie Chen, et al.
Published: (2025-06-01) -
Serum miRNA-186-3P and miRNA-382-3P constitute a novel Diagnostic miRNA signature for palindromic rheumatism
by: Fangfang Yuan, et al.
Published: (2025-03-01) -
Comparison of the effect of iguratimod and hydroxychloroquine on regulatory B cells in the treatment of primary Sjögren’s syndrome
by: Jin-Mei Zou, et al.
Published: (2025-07-01) -
Iguratimod improves bleomycin-induced pulmonary inflammation and fibrosis by regulating macrophage polarization through inhibiting the TLR4/NF-κB pathway
by: Huan Xu, et al.
Published: (2025-03-01) -
Palindromic Thinking in Contemporary Composition: Creative Techniques and Aesthetic Implications
by: Haiyue Wang, et al.
Published: (2023-12-01)